VENTURE CAPITAL POST

Bacterin International Holdings Inc has secured $4 million more in funding from OrbiMed and will be issuing 1.5 million shares of common stock to the investment firm as part of the deal, a statement about the funding said.

Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.

TigerText, a real-time messaging provider for the enterprise, has closed its Series B round led by Shasta Ventures with $21 million. New and existing investors also participated in the financing.